Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 408.3 | 323.5 | 240.6 | 213.5 |
| Revenue growth | 26.2% | 34.4% | 12.7% | |
| Cost of goods sold | 80.5 | 55.2 | 41.1 | 33.1 |
| Gross profit | 327.8 | 268.3 | 199.5 | 180.4 |
| Gross margin | 80.3% | 82.9% | 82.9% | 84.5% |
| Sales and marketing | 106.3 | 86.4 | 65.8 | 71.3 |
| Research and development | 76.4 | 67.0 | 49.0 | 40.4 |
| General and administrative | 79.7 | 79.0 | 32.9 | 32.1 |
| EBITA | 55.0 | 26.2 | 44.2 | 30.4 |
| EBITA margin | 13.5% | 8.1% | 18.4% | 14.3% |
| Amortization of intangibles | 39.9 | 52.6 | 58.1 | 64.2 |
| EBIT | 15.2 | -26.4 | -13.9 | -33.8 |
| EBIT margin | 3.7% | -8.2% | -5.8% | -15.8% |
| Pre-tax income | 13.1 | -56.0 | -45.5 | -66.8 |
| Income taxes | 2.3 | 3.5 | 13.1 | 15.4 |
| Tax rate | 17.5% | | | |
| Net income | 13.1 | -56.0 | -45.5 | -66.8 |
| Net margin | 3.2% | -17.3% | -18.9% | -31.3% |
| |
| Diluted EPS | $0.08 | ($0.39) | ($0.34) | ($0.51) |
| Shares outstanding (diluted) | 157.3 | 143.5 | 134.0 | 131.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|